|
Synonyms: QL-1604 | QL1604
iparomlimab is an approved drug
Compound class:
Antibody
Comment: Iparomlimab (QL1604) is a humanized monoclonal antibody against programmed cell death protein 1 (PD-1). It blocks the inhibitory PD-1/PD-L1/2 immune checkpoint.
|
| References |
|
1. Xiong J, Ouyang W, Yang M, Gao Z, Zhou H, Lou H, Guo Y, Xu Z, Zheng L, Liu Y et al.. (2024)
Efficacy and Safety of Iparomlimab, an Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors: A Phase 1c Study. Adv Ther, 41 (11): 4153-4171. [PMID:39276185] |
